Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLB vs ESB for Hip PAO Pain
NCT04481451Phase 4Withdrawn
- Sponsor
- Boston Children's Hospital
- Start
- Dec 2020
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in postoperative pain, sponsored by Boston Children's Hospital. Primary endpoint: Rescue analgesic consumption at 24 hours. Planned start Dec 2020; status: withdrawn.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04481451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04481451.